(71 days)
No
The document describes a mechanical implant (patellar component) and its materials, intended use, and performance testing demonstrating equivalence to predicate devices. There is no mention of software, algorithms, image processing, AI, ML, or data sets for training or testing.
Yes
This medical device is a patellar component of a knee system, indicated for conditions like osteoarthritis, rheumatoid arthritis, and correction of functional deformities. These uses are directly related to treating or alleviating a disease, injury, or medical condition, which aligns with the definition of a therapeutic device.
No
The device is a patellar component for a knee replacement system, used for treatment of joint diseases, not for diagnosing them.
No
The device description clearly states it is fabricated from physical materials (Hedrocel® and UHMWPE) and is a physical component intended for surgical implantation.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health.
- Device Description and Intended Use: The provided text clearly describes a physical implantable device – a patellar component for a knee replacement system. Its intended use is to be surgically implanted to treat various knee conditions.
- Lack of Diagnostic Activity: There is no mention of this device being used to analyze samples or provide diagnostic information. It is a therapeutic device used in surgery.
The information provided describes a medical device used in vivo (within the body) for treatment, not in vitro (in glass/outside the body) for diagnosis.
N/A
Intended Use / Indications for Use
The Continuum Patellar is intended as the patellar component of the Continuum Knee System whose indications for use include: 1) noninflamatory degenerative joint disease including osteoarthritis or traumatic arthritis, 2) rheumatoid arthritis, 3) correction of functional deformity, 4) revision procedures where other treatments or devices have failed, and 5) treatment of fractures that are unmanageable using other techniques. This device is intended for use with bone cement.
Product codes
JWH
Device Description
The Continuum Patellar is fabricated from Hedrocel® and UHMWPE. The UHMWPE is direct compression molded into the Hedrocel®, thereby creating the articulation surface. The Continuum Patellar is intended for use with bone cement when performing total knee arthroplasty or revisions with legally marketed Implex Continuum Femoral and Tibial components.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Patellar, Knee Joint
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance testing of the Continuum Patellar demonstrates its equivalence to the claimed predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3560 Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis.
(a)
Identification. A knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components and a retropatellar resurfacing component made of ultra-high molecular weight polyethylene. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.
0
JUL 2 4 1997
K971789
510(k) SUMMARY - CONTINUUM PATELLAR
| Submitter Name: | Implex Corp. (Implex) | ||
|---|---|---|---|
| Submitter Address: | 80 Commerce Drive | ||
| Allendale, New Jersey 07401-1600 | |||
| Contact Person: | Robert Cohen | ||
| Vice President, Product Development | |||
| Phone Number: | (201) 818-1600 | ||
| Fax Number: | (201) 818-0567 | ||
| Date Prepared: | July 22, 1997 | ||
| Device Trade Name: | Continuum Patellar | ||
| Device Common | |||
| Name: | Prosthesis, Patellar | ||
| Classification Name: | Knee Joint Patellofemorotibial Polymer/Metal/Polymer | ||
| Semi-Constrained Cemented Prosthesis | |||
| Predicate Device(s): | Patellar Component of Continuum Knee System (CKS), | ||
| Implex Corp. (K882322); Porous Genesis Patellar, | |||
| Richards Medical Company (K890132); Duracon Inset | |||
| Patella with Central Peg, Howmedica (K961482). | |||
| Device Description: | The Continuum Patellar is fabricated from Hedrocel® and | ||
| UHMWPE. The UHMWPE is direct compression molded | |||
| into the Hedrocel®, thereby creating the articulation surface. | |||
| The Continuum Patellar is intended for use with bone | |||
| cement when performing total knee arthroplasty or revisions | |||
| with legally marketed Implex Continuum Femoral and Tibial | |||
| components. | |||
| Intended Use: | The Continuum Patellar is intended as the patellar | ||
| component of the Continuum Knee System whose | |||
| indications for use include: 1) noninflamatory degenerative | |||
| joint disease including osteoarthritis or traumatic arthritis, |
- rheumatoid arthritis, 3) correction of functional
deformity, 4) revision procedures where other treatments or
devices have failed, and 5) treatment of fractures that are
unmanageable using other techniques. This device is
intended for use with bone cement. | | |
1
_510(k) Summary (continued)
| Device
Technological
Characteristics and
Comparison to
Predicate Device(s): | The two-part design and articulating surface geometry of the
Continuum Patellar is similar and/or identical to the claimed
predicate devices from Implex Corp., Richards Medical
Company, and Howmedica. |
|-----------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Performance Data: | Performance testing of the Continuum Patellar demonstrates
its equivalence to the claimed predicate devices. |
| Conclusion: | The Continuum Patellar is substantially equivalent to the
predicate devices in terms of intended use, safety, and
effectiveness. |
2
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three human profiles incorporated into its body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 2 4 1997
Glenn N. Byrd, MBA Associate Director of Requlatory Affairs Authorized Regulatory Agent for Implex Corporation -----------Advanced Bioresearch Associates 1700 Rockville Pike, Suite 450 Rockville, Maryland 20852
Re: K971789 Implex Continuum Porous Patellar Regulatory Class: II Product Code: JWH Dated: May 14, 1997 Received: May 14, 1997
Dear Mr. Byrd:
We have reviewed your Section 510 (k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). This decision is based on this device being equivalent only to similar devices labeled and intended to be fixed within bone with acrylic "bone cement." You may, therefore, market your device subject to the general controls provisions of the Act and the following limitation:
-
- This device may not be labeled or promoted for non-cemented use.
-
- All labeling for this device, including package label and labeling included within the package, must prominently state that the device is intended for cemented use only.
3
Page 2 - Glen N. Byrd, MBA
- Any non-cemented fixation of this device is 3. considered investigational and may only be investigated as a significant risk device in accordance with the investigational device exemption --------(IDE) regulation under 21 CFR, Part 812. All users ^ of the device for non-cemented fixation must receive approval from their respective institutional review boards (IRBs) and the Food and Drug Administration (FDA) to conduct the investigation.
The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practices, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal Laws on Regulations .
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification immediately. An FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and permits your device to proceed to the market.
4
Page 3 - Glenn N. Byrd, MBA
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other qeneral information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 at (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Celia M. Witten, Ph.D., M.D.
Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
510(k) Number (if known):
Device Name:
lmplex Continuum Porous Patellar
Indications For Use:
The Implex Continuum Porous Patellar is intended as the patellar component of the Continuum Knee System whose indications for use include: 1) noninflamatory degenerative joint disease including osteoarthritis or traumatic arthritis, 2) rheumatoid arthritis, 3) correction of functional deformity, 4) revision procedures where other treatments or devices have failed, and 5) treatment of fractures that are unmanageable using other techniques. This device is intended for use with bone cement.
-- K971789
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
| Concurrence of CDRH; Office of Device Evaluation (ODE) | |
|---|---|
| (Division Sign-Off) | |
| Division of General Restorative Devices | |
| 510(k) Number | K971789 |
| Prescription Use | X | OR... | Over-The-Counter Use |
|---|---|---|---|
| (Per 21 CFR 801.109) |
(Optional Format 1-2-96)